Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

News and Events

NewsEvents

High Court re-confirms Actavis approach for determining claim scope of variants

Date: 24 November 2017

EmailTwitterLinkedInXingWeChat

Fisher & Paykel Healthcare Ltd v Resmed Ltd [2017] EWHC 2748 (10 November 2017)

 

Hot on the heels of the Supreme Court's ruling in Eli Lilly v Actavis UK Ltd (see our full analysis here), the High Court has confirmed for the second time that the "Actavis approach" is now the law for determining claim scope of variants.

 

Our partner Alvin Lam has written a brief analysis of the case, available here. This article was first published by Lexis®PSL on 17 November 2017.

 

For questions about this matter or related issues, please contact our Partner Alvin Lam.

 

 

C
This site uses cookies.

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy

Necessary Cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytical Cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

x